Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 216,174 | 292,887 | 216,833 | 181,398 | 120,915 |
| Cost of Goods | 74,826 | 71,973 | 69,327 | 67,713 | 63,852 |
| Gross Profit | 141,348 | 220,914 | 147,506 | 113,685 | 57,063 |
| Operating Expenses | 136,892 | 133,476 | 115,191 | 132,387 | 115,866 |
| Operating Income | 5,282 | 88,412 | 32,642 | -17,989 | -57,952 |
| Interest Expense | 12,809 | 11,356 | 13,507 | 19,208 | 12,782 |
| Other Income | 6,883 | 4,902 | 5,190 | -34,593 | -31,847 |
| Pre-tax Income | -644 | 81,958 | 24,325 | -71,790 | -102,581 |
| Income Tax | -134 | N/A | 0 | N/A | N/A |
| Net Income Continuous | -510 | 81,958 | 24,325 | -71,790 | -102,581 |
| Net Income | $-510 | $81,958 | $24,325 | $-71,790 | $-102,581 |
| EPS Basic Total Ops | 0.00 | 8.23 | 0.09 | -7.97 | -3.57 |
| EPS Basic Continuous Ops | 0.00 | 3.49 | 0.09 | -1.11 | -2.88 |
| EPS Diluted Total Ops | 0.00 | 8.24 | 0.08 | -7.97 | -3.57 |
| EPS Diluted Continuous Ops | 0.00 | 3.50 | 0.08 | -1.11 | -2.88 |
| EPS Diluted Before Non-Recurring Items | 0.00 | 0.28 | 0.08 | -0.54 | N/A |
| EBITDA(a) | $12,971 | $93,307 | $39,975 | $-3,825 | $-48,961 |